Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01727154 · ClinicalTrials.gov registry record
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
A clinical trial, sponsored by Dendreon.
- Terminated
- Registry status
- 139
- Enrollment target
NCT01727154 is a clinical trial that was terminated before completion, run by Dendreon. The registered enrollment target is 139 participants.
The verdict
NCT01727154 was terminated before completion, sponsored by Dendreon.
- TERMINATED
- Registry status
- 139 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).
Interventions
- BIOLOGICAL Sipuleucel-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2012-10 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01727154
The ClinicalTrials.gov registry entry for NCT01727154 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dendreon, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sipuleucel-T is the first listed.
NCT01727154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01727154 about?
NCT01727154 is a clinical study titled "Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T". The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).
What is the current status of trial NCT01727154?
This trial is currently terminated. The enrollment target is 139 participants. The study started on 2012-10. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01727154?
The interventions under investigation include: Sipuleucel-T (BIOLOGICAL).
Who is sponsoring clinical trial NCT01727154?
This trial is sponsored by Dendreon, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.